9 commercial payer policies list J0225. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
9 policies from 7 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J0225 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| RNA-Targeted Therapies (Amvuttra and Onpattro) | Jun 1, 2026 | Covered |
| Policy | Effective | Status of J0225 |
|---|---|---|
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| RNA-Targeted Therapies (Amvuttra and Onpattro) | Jun 1, 2026 | Covered |
| Policy | Effective | Status of J0225 |
|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of J0225 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0225 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0225 |
|---|---|---|
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0225 |
|---|---|---|
| RNA-Targeted Therapies (Amvuttra and Onpattro) | Jun 1, 2026 | Covered |